Name: PRECIGEN INC (PGEN) Stock
Brand: PRECIGEN INC
Rating: 5.5 (3 reviews)

PGEN Latest News, Press Relases and Analysis

All

Press Releases

18 days ago - By: Chartmill - Mentions: CDTX AVXL SRRK KXIN ...

Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session.

18 days ago - By: Chartmill

Precigen Inc (NASDAQ:PGEN) Q3 2025 Earnings: Revenue Soars But Wider Loss Dampens Investor Sentiment

18 days ago - By: Benzinga - Mentions: PTN ZYXI AVXL CDTX ...

12 Health Care Stocks Moving In Friday's Intraday Session

18 days ago - By: The Motley Fool

Precigen (PGEN) Q3 2025 Earnings Call Transcript

19 days ago - By: Precigen, Inc.

Precigen Reports Third Quarter 2025 Financial Results and Business Updates

20 days ago - By: Benzinga

Exploring Precigen's Earnings Expectations

26 days ago - By: Precigen, Inc.

Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13

a month ago - By: The Motley Fool - Mentions: C UNH QXO AMZN

Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares

2 months ago - By: Precigen, Inc.

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis

3 months ago - By: Precigen, Inc.

Precigen Announces Up to $125 Million Non-Dilutive Financing

3 months ago - By: Zacks Investment Research - Mentions: INO CRMD KNSA

INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug

3 months ago - By: Yahoo Finance

Citizens JMP Raises PT on Precigen from $6 to $8, Keeps Outperform Rating